The PI3K Pathway in Human Disease

Clicks: 214
ID: 119730
2017
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Phosphoinositide 3-kinase (PI3K) activity is stimulated by diverse oncogenes and growth factor receptors, and elevated PI3K signaling is considered a hallmark of cancer. Many PI3K pathway-targeted therapies have been tested in oncology trials, resulting in regulatory approval of one isoform-selectiv …
Reference Key
da2017cellthe Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Fruman DA;Chiu H;Hopkins BD;Bagrodia S;Cantley LC;Abraham RT;;
Journal Cell
Year 2017
DOI DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.